Dabrafenib,trade name Tafinlar,is a drug for the treatment of cancers associated with a mutated version of the gene BRAF - especially skin cancer. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf,which plays a role in the regulation of cell growth. Dabrafenib has clinical activity with a safety profile in patients with BRAF(V600)-mutated metastatic melanoma | |
Licence : | Libre de droits |
Crédit: | Science Photo Library / Pasieka, Alfred |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |